Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 233

1.

Author response.

Aarli JA, Abramsky O.

Neurology. 2014 Feb 25;82(8):734. No abstract available.

PMID:
24707539
2.

When is a global health program global?

Aarli JA, Abramsky O.

Neurology. 2013 Jun 4;80(23):2088-9. doi: 10.1212/WNL.0b013e318295d73d. No abstract available.

PMID:
23733550
3.

Myasthenia gravis.

Aarli JA, Gilhus NE, Lisak RP, Mantegazza R, Suzuki S.

Autoimmune Dis. 2011;2011:697575. doi: 10.4061/2011/697575. Epub 2012 Jan 24. No abstract available.

4.

Myasthenia gravis: a review of available treatment approaches.

Gilhus NE, Owe JF, Hoff JM, Romi F, Skeie GO, Aarli JA.

Autoimmune Dis. 2011;2011:847393. doi: 10.4061/2011/847393. Epub 2011 Oct 5.

5.

Global perspectives.

Khalifa A, Aarli JA.

Neurology. 2011 Oct 18;77(16):1565-7. doi: 10.1212/WNL.0b013e318236856c. No abstract available.

PMID:
22006888
6.

Neurological effects of deep diving.

Grønning M, Aarli JA.

J Neurol Sci. 2011 May 15;304(1-2):17-21. doi: 10.1016/j.jns.2011.01.021. Epub 2011 Mar 4. Review.

PMID:
21377169
7.

Neurological perspectives on person-centered medicine.

Aarli JA.

Int J Integr Care. 2010 Jan 29;10 Suppl:e006. No abstract available.

8.

Herzmyasthenie: myasthenia of the heart.

Aarli JA.

Arch Neurol. 2009 Nov;66(11):1322-3. doi: 10.1001/archneurol.2009.231. No abstract available.

PMID:
19901161
9.

Chapter 41: the history of neurology in Scandinavia.

Aarli JA, Stien R.

Handb Clin Neurol. 2010;95:657-66. doi: 10.1016/S0072-9752(08)02141-6.

PMID:
19892144
10.

Neurology and psychiatry: "Oh, East is East and West is West ...".

Aarli JA.

Neuropsychiatr Dis Treat. 2005 Dec;1(4):285-6. No abstract available.

11.

Myasthenia gravis in the elderly: Is it different?

Aarli JA.

Ann N Y Acad Sci. 2008;1132:238-43. doi: 10.1196/annals.1405.040.

PMID:
18567874
12.

The wind of change.

Aarli JA.

Arch Neurol. 2007 Dec;64(12):1694-5. No abstract available.

PMID:
18071031
13.

Neurology in sub-Saharan Africa: a challenge for World Federation of Neurology.

Aarli JA, Diop AG, Lochmüller H.

Neurology. 2007 Oct 23;69(17):1715-8. Review. No abstract available.

PMID:
17954787
14.

Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features.

Romi F, Aarli JA, Gilhus NE.

Eur J Neurol. 2007 Jun;14(6):617-20.

PMID:
17539937
15.

Post-polio syndrome patients treated with intravenous immunoglobulin: a double-blinded randomized controlled pilot study.

Farbu E, Rekand T, Vik-Mo E, Lygren H, Gilhus NE, Aarli JA.

Eur J Neurol. 2007 Jan;14(1):60-5.

PMID:
17222115
16.

Myasthenia gravis: disease severity and prognosis.

Romi F, Gilhus NE, Aarli JA.

Acta Neurol Scand Suppl. 2006;183:24-5.

PMID:
16637923
17.

Titin and ryanodine receptor antibodies in myasthenia gravis.

Skeie GO, Aarli JA, Gilhus NE.

Acta Neurol Scand Suppl. 2006;183:19-23. Review.

PMID:
16637922
18.

WHO/WFN Survey of neurological services: a worldwide perspective.

Janca A, Aarli JA, Prilipko L, Dua T, Saxena S, Saraceno B.

J Neurol Sci. 2006 Aug 15;247(1):29-34. Epub 2006 Apr 19.

PMID:
16624322
19.

Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis.

Sanders DB, Aarli JA, Cutter GR, Jaretzki A 3rd, Kaminski HJ, Phillips LH 2nd.

Neurology. 2006 Mar 28;66(6):954-5; author reply 954-5. No abstract available.

PMID:
16567729
20.

The clinical significance of spinal cord injuries in patients older than 60 years of age.

Hagen EM, Aarli JA, Gronning M.

Acta Neurol Scand. 2005 Jul;112(1):42-7.

PMID:
15932355
21.

Seronegative myasthenia gravis: disease severity and prognosis.

Romi F, Aarli JA, Gilhus NE.

Eur J Neurol. 2005 Jun;12(6):413-8.

PMID:
15885043
22.

Striational antibodies in myasthenia gravis: reactivity and possible clinical significance.

Romi F, Skeie GO, Gilhus NE, Aarli JA.

Arch Neurol. 2005 Mar;62(3):442-6. Review.

PMID:
15767509
23.

Myasthenia gravis: clinical, immunological, and therapeutic advances.

Romi F, Gilhus NE, Aarli JA.

Acta Neurol Scand. 2005 Feb;111(2):134-41. Review.

PMID:
15644074
24.

The role of complement in myasthenia gravis: serological evidence of complement consumption in vivo.

Romi F, Kristoffersen EK, Aarli JA, Gilhus NE.

J Neuroimmunol. 2005 Jan;158(1-2):191-4.

PMID:
15589053
25.

[Intravenous immunoglobulin in postpolio syndrome].

Farbu E, Rekand T, Gilhus NE, Strøm V, Opheim A, Stanghelle JK, Aarli JA.

Tidsskr Nor Laegeforen. 2004 Sep 23;124(18):2357-8. Norwegian.

26.

[Thymectomy and muscle antibodies in myasthenia gravis].

Romi F, Gilhus NE, Aarli JA.

Tidsskr Nor Laegeforen. 2004 Mar 4;124(5):629-31. Norwegian.

27.

Lifestyle and late effects after poliomyelitis. A risk factor study of two populations.

Rekand T, Kõrv J, Farbu E, Roose M, Gilhus NE, Langeland N, Aarli JA.

Acta Neurol Scand. 2004 Feb;109(2):120-5.

PMID:
14705974
28.

[Skeletons in the cupboard--treatment of Arne Torkildsen].

Stien R, Aarli JA.

Tidsskr Nor Laegeforen. 2003 Dec 23;123(24):3588-91. Norwegian.

29.

Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study.

Romi F, Gilhus NE, Varhaug JE, Myking A, Aarli JA.

Eur J Neurol. 2003 Nov;10(6):701-6.

PMID:
14641516
30.

Neuroborreliosis with vasculitis causing stroke-like manifestations.

Romi F, Kråkenes J, Aarli JA, Tysnes OB.

Eur Neurol. 2004;51(1):49-50. Epub 2003 Nov 21. No abstract available.

PMID:
14639033
31.

Detection of viral sequences in archival spinal cords from fatal cases of poliomyelitis in 1951-1952.

Rekand T, Male R, Myking AO, Nygaard SJ, Aarli JA, Haarr L, Langeland N.

J Virol Methods. 2003 Dec;114(1):91-6.

PMID:
14599683
32.

Thymectomy and antimuscle antibodies in nonthymomatous myasthenia gravis.

Romi F, Gilhus NE, Varhaug JE, Myking A, Skeie GO, Aarli JA.

Ann N Y Acad Sci. 2003 Sep;998:481-90.

PMID:
14592917
33.

Myasthenia gravis in individuals over 40.

Aarli JA, Romi F, Skeie GO, Gilhus NE.

Ann N Y Acad Sci. 2003 Sep;998:424-31.

PMID:
14592910
34.

Pathogenesis of myositis and myasthenia associated with titin and ryanodine receptor antibodies.

Skeie GO, Romi F, Aarli JA, Bentsen PT, Gilhus NE.

Ann N Y Acad Sci. 2003 Sep;998:343-50. Review.

PMID:
14592894
35.

Role of cytokines in neurological disorders.

Aarli JA.

Curr Med Chem. 2003 Oct;10(19):1931-7. Review.

PMID:
12871095
36.

Thymectomy for myasthenia gravis: evaluation requires controlled prospective studies.

Jaretzki A 3rd, Aarli JA, Kaminski HJ, Phillips LH 2nd, Sanders DB; Medical/Scientific Advisory Board, Myasthenia Gravis Foundation of America, Inc.

Ann Thorac Surg. 2003 Jul;76(1):1-3. No abstract available.

PMID:
12842502
37.

[When can the diagnosis of multiple sclerosis be confirmed?].

Aarli JA.

Tidsskr Nor Laegeforen. 2003 May 15;123(10):1316. Norwegian. No abstract available.

38.

GM1 antibodies in post-polio syndrome and previous paralytic polio.

Farbu E, Rekand T, Tysnes OB, Aarli JA, Gilhus NE, Vedeler CA.

J Neuroimmunol. 2003 Jun;139(1-2):141-4.

PMID:
12799031
39.

Thymectomy in nonthymoma early-onset myasthenia gravis in correlation with disease severity and muscle autoantibodies.

Romi F, Gilhus NE, Varhaug JE, Myking A, Aarli JA.

Eur Neurol. 2003;49(4):210-7.

PMID:
12736536
40.

Long term outcome after poliomyelitis in different health and social conditions.

Rekand T, Kõrv J, Farbu E, Roose M, Gilhus NE, Langeland N, Aarli JA.

J Epidemiol Community Health. 2003 May;57(5):368-72.

41.

Preoperative preparation of patients with myasthenia gravis forestalls postoperative respiratory complications after thymectomy.

Jaretzki A 3rd, Aarli JA, Kaminski HJ, Phillips LH 2nd, Sanders DB.

Ann Thorac Surg. 2003 Mar;75(3):1068; author reply 1069. No abstract available.

PMID:
12645760
42.

Ryanodine receptor antibodies in myasthenia gravis: epitope mapping and effect on calcium release in vitro.

Skeie GO, Mygland A, Treves S, Gilhus NE, Aarli JA, Zorzato F.

Muscle Nerve. 2003 Jan;27(1):81-9.

PMID:
12508299
43.

Fcgamma receptor IIIA polymorphism as a risk factor for acute poliomyelitis.

Rekand T, Langeland N, Aarli JA, Vedeler CA.

J Infect Dis. 2002 Dec 15;186(12):1840-3. Epub 2002 Nov 19.

PMID:
12447772
44.

Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules.

Romi F, Bø L, Skeie GO, Myking A, Aarli JA, Gilhus NE.

J Neuroimmunol. 2002 Jul;128(1-2):82-9.

PMID:
12098514
45.

Long-term follow-up of patients with nonparalytic poliomyelitis.

Rekand T, Karlsen B, Langeland N, Aarli JA.

Arch Phys Med Rehabil. 2002 Apr;83(4):533-7.

PMID:
11932857
46.

Cystic dilation of Virchow-Robin spaces in the midbrain.

Romi F, Tysnes OB, Kråkenes J, Savoiardo M, Aarli JA, Bindoff L.

Eur Neurol. 2002;47(3):186-8. No abstract available.

PMID:
11914561
47.

[Patients with traumatic spinal cord injuries at the department of neurology, Haukeland Hospital 1952-99].

Hagen EM, Aarli JA, Grønning M.

Tidsskr Nor Laegeforen. 2001 Nov 20;121(28):3273-5. Norwegian.

48.

Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis.

Romi F, Gilhus NE, Varhaug JE, Myking A, Skeie GO, Aarli JA.

Eur J Neurol. 2002 Jan;9(1):55-61.

PMID:
11784377
49.

Polio survivors--well educated and hard working.

Farbu E, Rekand T, Aarli JA, Gilhus NE.

J Neurol. 2001 Jun;248(6):500-5.

PMID:
11499641
50.

[Acute infectious myelitis].

Skulstad S, Aarli JA.

Tidsskr Nor Laegeforen. 2001 Jun 10;121(15):1817-20. Review. Norwegian.

PMID:
11464688

Supplemental Content

Loading ...
Support Center